Beta: Sign in
Shares outstandingAs of 2026-03-27 · listed ADS: 251.20M
Shares float: Sign in
Float %: Sign in
Insider ownershipDirectors and officers, from their latest Form 3/4/5 holding: 0.00%
Institutional ownership: Sign in
Short interestShare of shares outstanding, at settlement: 0.92%
Short ratioDays to cover, as published by FINRA: 1.00
Short volume (5D)Share of FINRA reporting-facility volume sold short, daily flow: 32.90%
Short volume (20D)Share of FINRA reporting-facility volume sold short, daily flow: 37.20%
Avg volume (10D)

See the full stock page

Prices, charts, ranges, valuation ratios, dividends, momentum and analyst estimates are licensed for signed-in members. A free account opens every stock, fund and crypto page.

Create free account

Source: SEC filings. Information and analytics, not investment advice.

Loading evidence for BNTX

Rev growth (fwd)

Avg volume (3 months)

Profitability

Gross marginFY Dec 25: 77.64%
Operating marginFY Dec 25: -48.95%
Net margin: —
EBITDA margin: —
Return on equityNet income (FY Dec 25) ÷ average shareholders equity: -5.88%
Return on assetsNet income (FY Dec 25) ÷ average total assets: -5.10%

Growth

Revenue growth (annual YoY): 4.32%
Revenue growth (latest qtr YoY): —
Revenue growth (fwd): Sign in
Net income growth (annual YoY): —
Net income growth (latest qtr YoY): —
EPS growth (fwd): Sign in
Net income growth (QoQ): —

Valuation

Market cap: Sign in
Enterprise value: Sign in
P/E: Sign in
P/E (fwd): Sign in
PEG: Sign in
PEG (fwd): Sign in
Price / book: Sign in
Price / sales: Sign in
Price / operating cash flow: Sign in
P/FCF: Sign in
EV / revenue: Sign in
EV / EBITDA: Sign in
EPSDiluted, FY Dec 25: -4.70
EPS (fwd): Sign in

Financial health

Cash & equivalentsas of Jun 26: EUR 9.74B
Total cash: Sign in
Total debtBorrowings + finance and operating lease liabilities, as of Dec 25: EUR 230.30M
Debt / equityas of Dec 25: 1.20%
Current ratioas of Jun 26: 7.85
Quick ratio(Cash + marketable securities + receivables) ÷ current liabilities, as of Dec 25: 7.38
Operating cash flowFY Dec 25: EUR 456.00M
Free cash flowUnadjusted FCF = CFO − capex · FY Dec 25: EUR 280.90M
TTM revenue / diluted shareDiluted, FY Dec 25: 11.87

BNTX stock Statistics — BioNTech SE filings, insiders & smart money · Instaport